Breaking News Instant updates and real-time market news.

APD

Air Products

$228.62

-0.15 (-0.07%)

, WLL

Whiting Petroleum

$8.65

0.04 (0.46%)

10:12
08/19/19
08/19
10:12
08/19/19
10:12

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Air Products (APD) downgraded to Neutral from Positive at Susquehanna. 2. Whiting Petroleum (WLL) downgraded to Sector Perform from Outperform at Scotiabank and to Equal Weight from Overweight at Stephens. 3. Celgene (CELG) and Amgen (AMGN) downgraded to Neutral from Buy at Mizuho. 4. Alliance Resource Partners (ARLP) and Peabody Energy (BTU) downgraded to Neutral from Overweight at JPMorgan. 5. Trillium Therapeutics (TRIL) downgraded to Neutral from Buy at H.C. Wainwright with analyst Swayampakula Ramakanth saying the stock's 80% drop in price to 26c per share from $1.32 in the last six months could "lead to a cash crunch," leaving significant risk for its ability to raise sufficient capital to fund ongoing clinical studies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

APD

Air Products

$228.62

-0.15 (-0.07%)

WLL

Whiting Petroleum

$8.65

0.04 (0.46%)

CELG

Celgene

$95.15

0.45 (0.48%)

AMGN

Amgen

$204.27

0.32 (0.16%)

ARLP

Alliance Resource Partners

$15.10

0.15 (1.00%)

BTU

Peabody Energy

$19.15

-0.03 (-0.16%)

TRIL

Trillium Therapeutics

$0.29

0.0097 (3.52%)

  • 22

    Aug

  • 27

    Aug

  • 03

    Sep

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

  • 23

    Sep

  • 08

    Oct

  • 09

    Oct

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

APD Air Products
$228.62

-0.15 (-0.07%)

08/01/19
HSBC
08/01/19
DOWNGRADE
Target $215
HSBC
Hold
Air Products downgraded to Hold from Buy at HSBC
HSBC analyst Sriharsha Pappu downgraded Air Products & Chemicals to Hold from Buy with a price target of $215, down from $217. The analyst cites valuation for the downgrade.
08/19/19
SUSQ
08/19/19
DOWNGRADE
SUSQ
Neutral
Air Products downgraded to Neutral from Positive at Susquehanna
08/01/19
08/01/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Prudential (PRU) downgraded to Neutral from Buy at B. Riley FBR with analyst Randy Binner citing the company's Q2 results. 2. SBA Communications (SBAC) downgraded to Neutral from Overweight at JPMorgan. 3. Air Products (APD) downgraded to Hold from Buy at HSBC with analyst Sriharsha Pappu citing valuation for the downgrade. 4. T2 Biosystems (TTOO) downgraded to Neutral from Buy at Alliance Global Partners. 5. Corning (GLW) downgraded to Neutral from Positive at Susquehanna with analyst Mehdi Hosseini downgraded Corning (GLW) to Neutral from Positive with analyst Mehdi Hosseini saying he moved to the sidelines until he is convinced earnings and CAGR can exceed the earnings from the S&P500. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/12/19
BMOC
08/12/19
NO CHANGE
Target $252
BMOC
Outperform
Air Products price target raised to $252 from $235 at BMO Capital
BMO Capital analyst John McNulty raised his price target on Air Products to $252 and kept his Outperform rating after meeting with its management, saying the discussions supported his conviction in the company's "significant" tailwinds. The analyst believes Air Products will continue to outperform the broader chemical and industrial space with strong pricing and capital deployment that will drive future growth.
WLL Whiting Petroleum
$8.65

0.04 (0.46%)

08/19/19
SPHN
08/19/19
DOWNGRADE
Target $14
SPHN
Equal Weight
Stephens downgrades Whiting Petroleum to Equal Weight, cuts target to $14
As previously reported, Stephens analyst Gail Nicholson downgraded Whiting Petroleum to Equal Weight from Overweight and cut her price target on the shares to $14 from $24 as she lowered her volume forecast for the second half of the year by 6% and trimmed her 2020 production forecast by 4% and increased her equity discount rate to reflect the market's bearish sentiment on oil. The company's Q2 volume miss and production guide down has created market skepticism that she believes will make the stock an in-line performer, barring a significant oil price improvement, Nicholson tells investors.
08/19/19
SCOT
08/19/19
DOWNGRADE
SCOT
Sector Perform
Whiting Petroleum downgraded to Sector Perform from Outperform at Scotiabank
08/19/19
SPHN
08/19/19
DOWNGRADE
SPHN
Equal Weight
Whiting Petroleum downgraded to Equal Weight from Overweight at Stephens
08/16/19
08/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. BHP Group (BHP) downgraded to Underperform from Neutral at BofA/Merrill with analyst Jason Fairclough saying the Chinese economy is likely to get worse before getting better. 2. Hexcel (HXL) downgraded to Sell from Neutral at Goldman Sachs with analyst Noah Poponak saying after re-rating year-to-date, the shares are the high-end of the historical valuation range. 3. Tapestry (TPR) downgraded to Perform from Outperform at Oppenheimer, to Neutral from Buy at MKM Partners, to Neutral from Conviction Buy at Goldman Sachs, to Neutral from Overweight at Piper Jaffray, and to Neutral from Outperform at Credit Suisse. 4. Whiting Petroleum (WLL) downgraded to Market Perform from Outperform at Wells Fargo with analyst Gordon Douthat saying the company's free cash generation potential is highly sensitive to oil price levels. 5. Best Inc (BEST) downgraded to Sector Weight from Overweight at KeyBanc with analyst Hans Chung citing the company's Q2 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CELG Celgene
$95.15

0.45 (0.48%)

08/19/19
MZHO
08/19/19
DOWNGRADE
MZHO
Neutral
Celgene downgraded to Neutral from Buy at Mizuho
08/19/19
MZHO
08/19/19
DOWNGRADE
MZHO
Neutral
Amgen, Celgene downgraded to Neutral on valuation at Mizuho
As previously reported, Mizuho analyst Salim Syed downgraded Amgen (AMGN) and Celgene (CELG), each to Neutral from Buy, "solely" on the stock's current trading prices nearing what the analyst views as appropriate valuations. Amgen has run up over the last week by about 10% following a "very clean Enbrel litigation win," but the stock price now gives full credit for its Enbrel IP, said Syed, who raised his price target on Amgen shares to $212 from $208. He also cut his price target on Celgene shares to $100 from $103, based on a calculation of one Bristol-Myers (BMY) share being worth $47, plus $50 cash per share and $3 for a risk-adjusted CVR valuation.
06/25/19
WBLR
06/25/19
NO CHANGE
WBLR
Outperform
Bristol-Myers sentiment suffered 'double hit' yesterday, says William Blair
William Blair analyst Matt Phipps said Bristol-Myers (BMY) suffered a "double hit to sentiment" yesterday with the news of both the CheckMate-459 trial failure in first-line hepatocellular carcinoma and delay of the closing of its Celgene (CELG) deal due to the required Otezla divestiture. He had previously modeled Opdivo sales in the front-line setting of over $1B and Otezla sales growing to $3B before loss of exclusivity in 2028 and decreased his out-year EPS estimates by over $1.00 due to yesterday's news. However, although near-term sentiment is dampened, he still sees a long-term opportunity, said Phipps, who keeps an Outperform rating on Bristol-Myers shares.
07/17/19
MZHO
07/17/19
NO CHANGE
Target $103
MZHO
Buy
Amgen seen by Mizuho as 'most likely' buyer of Celgene's Otezla
In the wake of the recent announcement that Bristol-Myers (BMY) plans to divest Otezla as part of its deal to acquire Celgene (CELG), Mizuho analyst Salim Syed said he has received questions on who could be a realistic buyer. He believes the "most likely" buyer would be Amgen (AMGN), followed by Johnson & Johnson (JNJ), which he would label as a "likely" buyer. Syed identifies the "less likely, but possible" buyers as Eli Lilly (LLY) and Regeneron (REGN). The analyst, who said Otezla is worth anywhere from $5B-$10B depending on the view of sales and synergy potential, keeps a Buy rating and $103 price target on Celgene shares.
AMGN Amgen
$204.27

0.32 (0.16%)

08/19/19
MZHO
08/19/19
DOWNGRADE
MZHO
Neutral
Amgen downgraded to Neutral from Buy at Mizuho
08/12/19
WELS
08/12/19
NO CHANGE
Target $202
WELS
Market Perform
Amgen price target raised to $202 from $197 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for Amgen to $202 from $197 following the positive District Court decision on ENBREL patents. With validity of ENBREL patents affirmed, the analyst also adjusted his sales estimates to reflect stable trends, and lack of biosimilar erosion beyond 2019. Nonetheless, Birchenough reiterates a Market Perform rating on the shares as he believes the stock is fully-valued relative to growth, even with upward revision to ENBREL estimates.
08/13/19
OPCO
08/13/19
NO CHANGE
Target $230
OPCO
Outperform
Amgen price target raised to $230 from $210 at Oppenheimer
Oppenheimer analyst Jay Olson raised his price target for Amgen (AMGN) to $230 from $210 after the U.S. District Court determined that Sandoz has not met the burden to prove all seven asserted claims invalid and upheld several Enbrel patents. The analyst suspects Sandoz will appeal but views the outcome as highly favorable for Amgen and models flat Enbrel sales until 2021 before declining. Sandoz is a division of Novartis (NVS). Olson reiterates an Outperform rating on Amgen's shares.
ARLP Alliance Resource Partners
$15.10

0.15 (1.00%)

08/19/19
JPMS
08/19/19
DOWNGRADE
Target $30
JPMS
Neutral
Peabody Energy downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst John Bridges downgraded Peabody Energy (BTU) to Neutral from Overweight, saying coal stock prices have fallen well below his and the Street's price targets based on long-term value, and cites the rising risk of recession for the downgrade as he feels better entry points could develop. The analyst, who also downgraded Alliance Resource Partners (ARLP), lowered his price target to $30 from $35 to highlight the potential of the coal stocks to deliver a tobacco-like recovery on the basis that while the sector's products are unpopular they are still needed.
07/29/19
GHSC
07/29/19
DOWNGRADE
GHSC
Neutral
Alliance Resource Partners downgraded to Neutral from Buy at Seaport Global
08/19/19
JPMS
08/19/19
DOWNGRADE
Target $22
JPMS
Neutral
Alliance Resource Partners downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst John Bridges downgraded Alliance Resource Partners (ARLP) to Neutral from Overweight, saying coal stock prices have fallen well below his and the Street's price targets based on long-term value, and cites the rising risk of recession for the downgrade as he feels better entry points could develop. The analyst, who also downgraded Peabody Energy (BTU), lowered his price target to $22 from $23 to highlight the potential of the coal stocks to deliver a tobacco-like recovery on the basis that while the sector's products are unpopular they are still needed.
07/29/19
GHSC
07/29/19
DOWNGRADE
GHSC
Neutral
Seaport Global downgrades Alliance Resource Partners to Neutral on weak view
As previously reported, Seaport Global analyst Mark Levin downgraded Alliance Resource Partners to Neutral from Buy after the company reported quarterly results that were much weaker than expected and management cut its full-year shipment and exports guidance. Given depressed export market conditions and low natural gas prices, he thinks there is at least some possibility the company's distribution coverage falls below 1.0x in calendar 2020, Levin tells investors.
BTU Peabody Energy
$19.15

-0.03 (-0.16%)

08/06/19
JEFF
08/06/19
DOWNGRADE
Target $18
JEFF
Hold
Peabody Energy downgraded to Hold from Buy at Jefferies
Jefferies analyst Christopher Lafemina downgraded Peabody Energy to Hold from Buy and lowered his price target for the shares to $18 from $27. A number of negative catalysts have emerged for miners, including the escalation of trade wars, devaluation of the yuan and tightening measures in the Chinese property market, Lafemina tells investors in a research note. Most miners have been relying on capital returns to attract investors, prioritizing dividends and share buy backs over new investments, says the analyst. However, he now expects declining earnings and free cash flow to drive declining capital returns, thereby removing a source of support for the stocks.
05/24/19
MKMP
05/24/19
NO CHANGE
Target $38
MKMP
Buy
Warrior Met Coal price target raised to $38 from $33 at MKM Partners
MKM Partners analyst Daniel Scott raised his price target on Warrior Met Coal (HCC) to $38 and kept his Buy rating as part of his broader research note titled "Coking Coal Staying Strong." The analyst maintains his multi-quarter view that the market for coking coal is "resilient" and demand is experiencing "continued strength" amid slow supply response from producers in Australia, U.S., and Canada. Scott adds that the $200 per metric ton price level is close to becoming a "new normal", while noting that valuation on the coking coal stocks is still "well below mid-cycle ranges". As part of his research note, the analyst also raises his FY19 and FY20 revenue and EBITDA forecasts for Peabody Energy (BTU) and Teck Resources (TECK).
TRIL Trillium Therapeutics
$0.29

0.0097 (3.52%)

03/12/19
HCWC
03/12/19
NO CHANGE
Target $4
HCWC
Buy
Trillium Therapeutics price target lowered to $4 from $10 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth lowered his price target for Trillium Therapeutics to $4 from $10 citing dilution from the recent capital raise and potential fund raises in the future. However, first look clinical results for TTI-622 in the second half of 2019 "could be a major catalyst for the stock," Ramakanth tells investors in a research note. He reiterates a Buy rating on the shares.
08/19/19
HCWC
08/19/19
DOWNGRADE
HCWC
Neutral
Trillium Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth downgraded Trillium Therapeutics to Neutral from Buy, stating that the stock's 80% drop in price to 26c per share from $1.32 in the last six months could "lead to a cash crunch," leaving significant risk for its ability to raise sufficient capital to fund ongoing clinical studies. Additionally, the company has been unable to secure a replacement and remains without a CEO since Niclas Stiernholm resigned on April 30, noted Ramakanth.

TODAY'S FREE FLY STORIES

VIVHY

Vivendi

$0.00

(0.00%)

, MDSO

Medidata

$91.77

-0.04 (-0.04%)

16:01
09/22/19
09/22
16:01
09/22/19
16:01
Periodicals
Vivendi to widen legal battle against Mediaset beyond Italy, Reuters says »

Vivendi (VIVHY) is taking…

VIVHY

Vivendi

$0.00

(0.00%)

MDSO

Medidata

$91.77

-0.04 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

15:57
09/22/19
09/22
15:57
09/22/19
15:57
Periodicals
Some WeWork board members seeing to remove Neumann as CEO, WSJ says »

A bloc of WeWork…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

15:54
09/22/19
09/22
15:54
09/22/19
15:54
Periodicals
SoftBank turns against WeWork's parent CEO, Reuters reports »

SoftBank (SFTBY), the…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$24.92

-0.28 (-1.11%)

, VIA

Viacom

$26.67

-0.85 (-3.09%)

15:48
09/22/19
09/22
15:48
09/22/19
15:48
Hot Stocks
Viacom acquires exclusive cable rights to Seinfeld from Sony Pictures Television »

Viacom (VIAB, VIA)…

VIAB

Viacom

$24.92

-0.28 (-1.11%)

VIA

Viacom

$26.67

-0.85 (-3.09%)

SNE

Sony

$59.19

-0.19 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

PWR

Quanta Services

$37.61

-0.28 (-0.74%)

12:22
09/22/19
09/22
12:22
09/22/19
12:22
Conference/Events
Quanta Services management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

PTEN

Patterson-UTI

$9.66

0.01 (0.10%)

12:21
09/22/19
09/22
12:21
09/22/19
12:21
Conference/Events
Patterson-UTI management to meet with Stephens »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ESE

Esco Technologies

$78.44

-1.54 (-1.93%)

12:19
09/22/19
09/22
12:19
09/22/19
12:19
Conference/Events
Esco Technologies management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

CSGP

CoStar Group

$595.10

-3.87 (-0.65%)

12:16
09/22/19
09/22
12:16
09/22/19
12:16
Conference/Events
CoStar Group participates in a conference call with Stephens »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 13

    Nov

CNNE

Cannae Holdings

$28.05

0.875 (3.22%)

12:02
09/22/19
09/22
12:02
09/22/19
12:02
Conference/Events
Cannae Holdings management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

ANDE

Andersons

$26.28

-0.56 (-2.09%)

12:01
09/22/19
09/22
12:01
09/22/19
12:01
Conference/Events
Andersons management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

XGN

Exagen

$18.16

-0.425 (-2.29%)

, DDOG

Datadog

$36.20

-1.26 (-3.36%)

08:40
09/22/19
09/22
08:40
09/22/19
08:40
On The Fly
Opening Day: Datadog rises over 50% in market debut »

Shares of Datadog surged…

XGN

Exagen

$18.16

-0.425 (-2.29%)

DDOG

Datadog

$36.20

-1.26 (-3.36%)

PING

Ping Identity

$19.25

-0.8 (-3.99%)

IGMS

IGM Biosciences

$21.00

-0.7 (-3.23%)

NVST

Envista

$28.80

0.75 (2.67%)

PTON

Peloton

$0.00

(0.00%)

EDR

Endeavor

$0.00

(0.00%)

OPRT

Oportun Financial

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

CSCO

Cisco

$49.59

0.38 (0.77%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 13

    Nov

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

PG

Procter & Gamble

$122.22

0.37 (0.30%)

, KO

Coca-Cola

$53.90

-0.62 (-1.14%)

08:17
09/21/19
09/21
08:17
09/21/19
08:17
Periodicals
Kellogg, Coca-Cola among staples stocks for dividends, Barron's says »

Consumer-staples stocks…

PG

Procter & Gamble

$122.22

0.37 (0.30%)

KO

Coca-Cola

$53.90

-0.62 (-1.14%)

PEP

PepsiCo

$134.49

-0.98 (-0.72%)

CL

Colgate-Palmolive

$70.97

0.01 (0.01%)

KMB

Kimberly-Clark

$135.13

0.9 (0.67%)

K

Kellogg

$63.79

0.07 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

  • 08

    Oct

  • 18

    Oct

  • 22

    Oct

  • 29

    Oct

  • 01

    Nov

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

, CMCSK

Comcast

$0.00

(0.00%)

08:09
09/21/19
09/21
08:09
09/21/19
08:09
Periodicals
Facebook, Microsoft among growth stocks for risky times, Barron's says »

Comcast (CMCSA), Delta…

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

CMCSK

Comcast

$0.00

(0.00%)

DAL

Delta Air Lines

$58.63

-0.05 (-0.09%)

FANG

Diamondback Energy

$96.90

-0.45 (-0.46%)

EHC

Encompass Health

$64.41

-0.01 (-0.02%)

FB

Facebook

$189.88

-0.27 (-0.14%)

JNJ

Johnson & Johnson

$131.73

1.75 (1.35%)

MSFT

Microsoft

$139.34

-1.74 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 01

    Oct

  • 02

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

YUM

Yum! Brands

$112.31

-1.83 (-1.60%)

, MCD

McDonald's

$209.44

-1.12 (-0.53%)

08:05
09/21/19
09/21
08:05
09/21/19
08:05
Periodicals
Fast food stock could gain if consumer spending slows, Barron's says »

Despite a surge in second…

YUM

Yum! Brands

$112.31

-1.83 (-1.60%)

MCD

McDonald's

$209.44

-1.12 (-0.53%)

CMG

Chipotle

$835.17

3.67 (0.44%)

CBRL

Cracker Barrel

$166.12

-0.23 (-0.14%)

WEN

Wendy's

$20.77

0.22 (1.07%)

QSR

Restaurant Brands

$72.64

-1.24 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 10

    Oct

  • 22

    Oct

  • 12

    Nov

  • 13

    Nov

SFTBF

SoftBank

$0.00

(0.00%)

, SFTBY

SoftBank

$0.00

(0.00%)

08:00
09/21/19
09/21
08:00
09/21/19
08:00
Periodicals
Softbank stock still attractive, Barron's says »

Investors seem convinced…

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REAL

RealReal

$17.00

0.21 (1.25%)

07:57
09/21/19
09/21
07:57
09/21/19
07:57
Periodicals
RealReal among year's more under-the-radar IPOs, Barron's says »

The RealReal is one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$64.28

0.65 (1.02%)

, WAB

Wabtec

$74.01

0.26 (0.35%)

07:48
09/21/19
09/21
07:48
09/21/19
07:48
Periodicals
Opioid crisis could hurt investors, Barron's says »

Opioid lawsuits have…

CVS

CVS Health

$64.28

0.65 (1.02%)

WAB

Wabtec

$74.01

0.26 (0.35%)

ABC

AmerisourceBergen

$85.13

0.475 (0.56%)

CAH

Cardinal Health

$47.89

-0.14 (-0.29%)

MCK

McKesson

$146.83

1.06 (0.73%)

MYL

Mylan

$21.01

0.03 (0.14%)

AMRX

Amneal Pharmaceuticals

$3.34

0.21 (6.71%)

ABT

Abbott

$83.56

0.35 (0.42%)

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

ENDP

Endo

$3.48

0.115 (3.42%)

TEVA

Teva

$7.44

-0.08 (-1.06%)

JNJ

Johnson & Johnson

$131.73

1.75 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 01

    Oct

  • 02

    Oct

  • 15

    Oct

  • 16

    Oct

  • 23

    Oct

  • 06

    Nov

  • 13

    Nov

DDAIF

Daimler AG

$0.00

(0.00%)

, FCAU

Fiat Chrysler

$13.52

-0.11 (-0.81%)

07:13
09/21/19
09/21
07:13
09/21/19
07:13
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$13.52

-0.11 (-0.81%)

F

Ford

$9.16

0.06 (0.66%)

GM

General Motors

$37.37

-0.41 (-1.09%)

HMC

Honda

$26.68

0.03 (0.11%)

NSANY

Nissan

$0.00

(0.00%)

TSLA

Tesla

$240.62

-5.89 (-2.39%)

TM

Toyota

$136.72

0.12 (0.09%)

VWAGY

Volkswagen

$0.00

(0.00%)

FB

Facebook

$189.88

-0.27 (-0.14%)

AGU

Agrium

$0.00

(0.00%)

ANDE

Andersons

$26.28

-0.56 (-2.09%)

ADM

Archer Daniels

$40.94

0.05 (0.12%)

BG

Bunge

$55.91

-0.26 (-0.46%)

CF

CF Industries

$49.28

-0.76 (-1.52%)

CMP

Compass Minerals

$56.29

-1.765 (-3.04%)

IPI

Intrepid Potash

$3.43

0.01 (0.29%)

POT

Potash

$0.00

(0.00%)

SYT

Syngenta

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 02

    Oct

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

UPS

UPS

$120.71

1.61 (1.35%)

21:22
09/20/19
09/20
21:22
09/20/19
21:22
Conference/Events
UPS management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

DIS

Disney

$132.18

-1.14 (-0.86%)

, T

AT&T

$37.92

0.78 (2.10%)

18:17
09/20/19
09/20
18:17
09/20/19
18:17
Periodicals
Disney reaches TV carriage agreement with AT&T, Bloomberg says »

The deal includes ESPN on…

DIS

Disney

$132.18

-1.14 (-0.86%)

T

AT&T

$37.92

0.78 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

BA

Boeing

$379.33

-5.28 (-1.37%)

18:15
09/20/19
09/20
18:15
09/20/19
18:15
Periodicals
Icelandair reaches deal for Boeing to cover costs associated with 737, WSJ says »

Icelandair Group said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

MCF

Contango Oil & Gas

$1.71

-0.07 (-3.93%)

17:58
09/20/19
09/20
17:58
09/20/19
17:58
Hot Stocks
Karlin Asset Management reports 11.4% passive stake in Contango Oil & Gas »

Karlin Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$142.97

1.68 (1.19%)

17:41
09/20/19
09/20
17:41
09/20/19
17:41
Hot Stocks
SPDR Gold Shares holdings rise to 894.15MT from 883.60MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXRT

Vaxart

$0.58

-0.0307 (-5.03%)

17:37
09/20/19
09/20
17:37
09/20/19
17:37
Syndicate
Vaxart files to sell 15.6M shares of common stock »

H.C. Wainwright acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

17:34
09/20/19
09/20
17:34
09/20/19
17:34
Periodicals
Apple given tariff exclusion on certain Mac Pro parts, Bloomberg says »

Apple has received U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.